Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

511
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
511
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Validation of a Method for the Simultaneous Determination of Pesticide Residues in Soybeans and Brown Rice by GC-MS/MS Using a Multi-Functional SPE-Based Sample Preparation Procedure].

Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan·2026
Same author

Altered mental status in cancer-related emergency hospitalizations: prevalence and recorded reasons for admission.

BMC emergency medicine·2026
Same author

A hypofunctional PREX1 variant (p.Y191C) leads to neurodevelopmental abnormalities and epilepsy by attenuating RAC1 signaling.

Scientific reports·2026
Same author

Environmental enrichment is associated with enhanced novel object recognition performance and an increased proportion of smooth endoplasmic reticulum-containing spines in the dentate gyrus of Septin3<sup>-/-</sup> mice.

Molecular brain·2026
Same author

Genetics and immunity in neuromyelitis optica spectrum disorder.

The Lancet. Neurology·2026
Same author

Impact of Preoperative Malnutrition and Sarcopenia on Clinical Outcomes After Transcatheter Aortic Valve Replacement.

Circulation reports·2026

Related Experiment Video

Updated: Jul 23, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K

Autoimmune-mediated astrocytopathy.

Makoto Kinoshita1, Tatsusada Okuno2

  • 1Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. mkinoshita@neurol.med.osaka-u.ac.jp.

Inflammation and Regeneration
|July 17, 2023
PubMed
Summary
This summary is machine-generated.

Autoimmune diseases targeting astrocytes in the central nervous system (CNS) are increasingly recognized. This review focuses on Aquaporin4 (AQP4)-mediated diseases, exploring clinical, pathological, and immunological aspects of anti-AQP4 antibody responses.

Keywords:
AQP4AstrocyteAutoimmunity

More Related Videos

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.5K
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
06:43

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

12.2K

Related Experiment Videos

Last Updated: Jul 23, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K
Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.5K
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
06:43

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

12.2K

Area of Science:

  • Neuroimmunology
  • Neuropathology
  • Autoimmunity

Background:

  • Astrocytes in the central nervous system (CNS) are identified as targets in autoimmune diseases.
  • Autoantibody-mediated responses against astrocytes are a recognized disease entity.
  • Aquaporin4 (AQP4) is the primary antigen in these astrocyte-targeted autoimmune conditions.

Purpose of the Study:

  • To review the clinical and pathological features of AQP4-mediated astrocyte diseases.
  • To discuss the pathogenic role of anti-AQP4 antibodies.
  • To explore recent findings on immune dysregulation leading to autoantibody production against astrocytes.

Main Methods:

  • Literature review of clinical studies.
  • Pathological analysis of affected CNS tissues.
  • Immunological investigation of autoantibody mechanisms.

Main Results:

  • Detailed description of clinical manifestations and pathological findings in AQP4-antibody-associated diseases.
  • Elucidation of the pathogenic role of anti-AQP4 antibodies in astrocyte damage.
  • Identification of potential mechanisms of immune dysregulation driving autoantibody production.

Conclusions:

  • AQP4-mediated astrocyte diseases represent a significant neuroimmunological entity.
  • Understanding the pathogenesis of anti-AQP4 antibodies is crucial for diagnosis and treatment.
  • Further research into immune dysregulation may reveal novel therapeutic targets.